New Publications

In the months of June - July 2022, we published 115 publications

Make yourself familiar with our Research Publication Authorship, Affiliation and Acknowledgements Policy (NSWHP_PD_026).

Make your publication count:

All NSW Health Pathology author affiliation must include the following elements in the following order;

  1. The name of the clinical service or specialty;
  2. NSW Health Pathology (not New South Wales Health Pathology or NSW Pathology);
  3. Location of the service or specialty;
  4. and any additional partnership affiliations (where applicable);
  5. City and State, Country.

For example: 

1Microbiology, NSW Health Pathology, Westmead Hospital and Institute of Clinical Pathology and Medical Research, Westmead, NSW, Australia. 

 

JULY 2022

  1. ASO Visual Abstract: Recursive Partitioning to Determine Order of Significance of Regional Metastasis Characteristics in Head and Neck Cutaneous Squamous Cell Carcinoma. Hurrell MJL, Heller GZ, Elliott MS, Gao K, Ebrahimi A, Clark JR, Shannon K, Palme CE, Wykes J, Gupta R, Ch'ng S, Nguyen KM, Low TH. Ann Surg Oncol. 2022 Jul 30. Q1 Surgery (SJR).
  2. De novo putative loss-of-function variants in TAF4 are associated with a neuro-developmental disorder. Janssen BDE, van den Boogaard MH, Lichtenbelt K, Seaby EG, Stals K, Ellard S, Newbury-Ecob R, Dixit A, Roht L, Pajusalu S, Õunap K, Firth HV, Buckley M, Wilson M, Roscioli T, Tidwell T, Mao R, Ennis S, Holwerda SJ, van Gassen K, van Jaarsveld RH. Hum Mutat. 2022 Jul 29. Q1 Genetics (SJR).
  3. Functional correlation of genome-wide DNA methylation profiles in genetic neurodevelopmental disorders. Levy MA, Relator R, McConkey H, Pranckeviciene E, Kerkhof J, Barat-Houari M, Bargiacchi S, Biamino E, Bralo MP, Cappuccio G, Ciolfi A, Clarke A, DuPont BR, Elting MW, Faivre L, Fee T, Ferilli M, Fletcher RS, Cherick F, Foroutan A, Friez MJ, Gervasini C, Haghshenas S, Hilton BA, Jenkins Z, Kaur S, Lewis S, Louie RJ, Maitz S, Milani D, Morgan AT, Oegema R, Østergaard E, Pallares NR, Piccione M, Plomp AS, Poulton C, Reilly J, Rius R, Robertson S, Rooney K, Rousseau J, Santen GWE, Santos-Simarro F, Schijns J, Squeo GM, John MS, Thauvin-Robinet C, Traficante G, van der Sluijs PJ, Vergano SA, Vos N, Walden KK, Azmanov D, Balci TB, Banka S, Gecz J, Henneman P, Lee JA, Mannens MMAM, Roscioli T, Siu V, Amor DJ, Baynam G, Bend EG, Boycott K, Brunetti-Pierri N, Campeau PM, Campion D, Christodoulou J, Dyment D, Esber N, Fahrner JA, Fleming MD, Genevieve D, Heron D, Husson T, Kernohan KD, McNeill A, Menke LA, Merla G, Prontera P, Rockman-Greenberg C, Schwartz C, Skinner SA, Stevenson RE, Vincent M, Vitobello A, Tartaglia M, Alders M, Tedder ML, Sadikovic B. Hum Mutat. 2022 Jul 29. Q1 Genetics (SJR).
  4. Landscape of Mutations in Early Stage Primary Cutaneous Melanoma - An InterMEL Study. Luo L, Shen R, Arora A, Orlow I, Busam KJ, Lezcano C, Lee TK, Hernando E, Gorlov I, Amos C, Ernstoff MS, Seshan V, Cust AE, Wilmott J, Scolyer RA, Mann G, Nagore E, Funchain P, Ko J, Ngo P, Edmiston SN, Conway K, Googe PB, Ollila D, Lee JE, Fang S, Rees JR, Thompson CL, Gerstenblith M, Bosenberg M, Gould Rothberg B, Osman I, Saenger Y, Reynolds AZ, Schwartz M, Boyce T, Holmen S, Brunsgaard E, Bogner P, Kuan PF, Wiggins C, Thomas NE, Begg CB, Berwick M; For InterMEL. Pigment Cell Melanoma Res. 2022 Jul 25. Q1 Biochemistry, Genetics and Molecular Biology (SJR).
  5. Anti-Ro52/TRIM21 serological subsets identify differential clinical and laboratory parameters. Lee AYS, Lin MW, Reed JH. Clin Rheumatol. 2022 Jul 23. Q1 Medicine (miscellaneous (SJR)).
  6. A comprehensive human leukocyte antigen analysis of 36 782 cord blood units stored in the Australian Public Cord Blood Banking Network. Klamer G, Sue J, Trickett A, Ko KH, Johnson P, Elwood NJ. Cytotherapy. 2022 Jul 21: S1465-3249(22)00682-X. Q1 Transplantation (SJR).
  7. Harmonizing factor assay-related testing performed in a large laboratory network. Favaloro EJ, Mohammed S, Vong R, Chapman K, Swanepoel P, Kershaw G, Cai N, Just S, Connelly L, Brighton T, Pasalic L. Blood Coagul Fibrinolysis. 2022 Jul 22. Q3 Hematology (SJR).
  8. Culture-Free Phylogenetic Analysis of Legionella pneumophila Using Targeted CRISPR/Cas9 Next-Generation Sequencing. Domazetovska A, Jensen SO, Gray M, Radzieta M, Maley M. Microbiol Spectr. 2022 Jul 11: e0035922. Q1 Cell Biology (SJR).
  9. Australian Gonococcal Surveillance Programme, 1 October to 31 December 2021. Lahra MM, Shoushtari M, Hogan TR. Commun Dis Intell (2018). 2022 Jul 21;46.
  10. Australian Meningococcal Surveillance Programme Annual Report, 2021. Lahra MM, George CR, Hogan TR. Commun Dis Intell (2018). 2022 Jul 21;46.
  11. Prognostic Role of the Platelet-Lymphocyte Ratio in Acute Ischemic Stroke Patients Undergoing Reperfusion Therapy: A Meta-Analysis. Sharma D, Bhaskar SMM. J Cent Nerv Syst Dis. 2022 Jul 15;14 :11795735221110373.
  12. Towards 50 years of platelet function analyser (PFA) testing. Favaloro EJ, Pasalic L, Lippi G. Clin Chem Lab Med. 2022 Jul 21. Q1 Biochemistry (medical (SJR)).
  13. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Shrestha LB, Foster C, Rawlinson W, Tedla N, Bull RA. Rev Med Virol. 2022 Jul 20: e2381. Q1 Infectious Diseases (SJR).
  14. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Moch H, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, Menon S, Raspollini MR, Rubin MA, Srigley JR, Hoon Tan P, Tickoo SK, Tsuzuki T, Turajlic S, Cree I, Netto GJ. Eur Urol. 2022 Jul 16: S0302-2838(22)02467-8. Q1 Urology (SJR).
  15. Weather extremes associated with increased Ross River virus and Barmah Forest virus notifications in NSW: learnings for public health response. Hime NJ, Wickens M, Doggett SL, Rahman K, Toi C, Webb C, Vyas A, Lachireddy K. Aust N Z J Public Health. 2022 Jul 19. Q2 Public Health, Environmental and Occupational (SJR).
  16. Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease. Moncrieff MD, Lo SN, Scolyer RA, Heaton MJ, Nobes JP, Snelling AP, Carr MJ, Nessim C, Wade R, Peach AH, Kisyova R, Mason J, Wilson ED, Nolan G, Pritchard Jones R, Johansson I, Olofsson Bagge R, Wright LJ, Patel NG, Sondak VK, Thompson JF, Zager JS. J Clin Oncol. 2022 Jul 18: JCO2102488. Q1 Cancer Research (SJR).
  17. D-dimer: old dogmas, new (COVID-19) tricks. Lippi G, Mullier F, Favaloro EJ. Clin Chem Lab Med. 2022 Jul 14. Q1 Biochemistry (medical (SJR)).
  18. Setting Bias Specifications Based on Qualitative Assays With a Quantitative Cutoff Using COVID-19 as a Disease Model. Lim CY, Chang WZ, Markus C, Horvath AR, Loh TP. Am J Clin Pathol. 2022 Jul 16: aqac072. Q1 Medicine (miscellaneous (SJR)).
  19. Key predictors and burden of meticillin-resistant Staphylococcus aureus in comparison with meticillin-susceptible S. aureus infections in an Australian hospital setting. Miyakis S, Brentnall S, Masso M, Reynolds G, Byrne MK, Newton P, Crawford S, Fish J, Nicholas B, Hill T, van Oijen AM; Wollongong Antimicrobial Resistance Research Alliance (WARRA); One Health Understanding Through Bacterial Resistance to Antibiotics Knowledge (OUTBREAK) Consortium. J Hosp Infect. 2022 Jul 12: S0195-6701(22)00220-1. Q1 Infectious Diseases (SJR).
  20. Third-party CMV- and EBV-specific T cells for first viral reactivation after allogeneic stem cell transplant. Jiang W, Clancy LE, Avdic S, Sutrave G, Street JA, Simms R, McGuire HM, Patrick E, Chan AS, McCaughan GJ, Myers N, Micklethwaite KP, Antonenas V, Selim AG, Ritchie DS, Bateman CM, Shaw PJ, Blyth E, Gottlieb DJ. Blood Adv. 2022 Jul 12: bloodadvances.2022007103. Q1 Hematology (SJR).
  21. Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms. Aung TN, Shafi S, Wilmott JS, Nourmohammadi S, Vathiotis I, Gavrielatou N, Fernandez A, Yaghoobi V, Sinnberg T, Amaral T, Ikenberg K, Khosrotehrani K, Osman I, Acs B, Bai Y, Martinez-Morilla S, Moutafi M, Thompson JF, Scolyer RA, Rimm DL. EBioMedicine. 2022 Jul 7;82: 104143. Q1 Biochemistry, Genetics and Molecular Biology (SJR).
  22. A biogeographical description of the wild waterbird species associated with high-risk landscapes of Japanese encephalitis virus in India. Walsh MG, Pattanaik A, Vyas N, Saxena D, Webb C, Sawleshwarkar S, Mukhopadhyay C. Transbound Emerg Dis. 2022 Jul 9. Q1 Medicine (miscellaneous (SJR)).
  23. D-dimers-"Normal" Levels versus Elevated Levels Due to a Range of Conditions, Including "D-dimeritis," Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19. Thachil J, Favaloro EJ, Lippi G. Semin Thromb Hemost. 2022 Jul 8. Q1 Cardiology and Cardiovascular Medicine (SJR).
  24. A Review of Autoimmune Acquired von Willebrand Factor Deficiency in Japan. Ichinose A, Osaki T, Souri M, Favaloro EJ. Semin Thromb Hemost. 2022 Jul 8. Q1 Cardiology and Cardiovascular Medicine (SJR).
  25. Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience. Favaloro EJ, Dean E, Arunachalam S. Semin Thromb Hemost. 2022 Jul 8. Q1 Cardiology and Cardiovascular Medicine (SJR).
  26. Up-regulation of ALK is associated with altered Wnt/beta-catenin pathway in adult pancreatoblastoma. Chou A, Sioson L, Sheen A, Ahadi MS, Gill AJ. Pathology. 2022 Jul 3: S0031-3025(22)00178-7. Q1 Pathology and Forensic Medicine.
  27. A functional platform for the selection of pathogenic variants of PMM2 amenable to rescue via the use of pharmacological chaperones. Segovia-Falquina C, Vilas A, Leal F, Del Caño-Ochoa F, Kirk EP, Ugarte M, Ramón-Maiques S, Gámez A, Pérez B. Hum Mutat. 2022 Jul 5. Q1 Genetics (SJR).
  28. Cross-Platform Omics Prediction procedure: a statistical machine learning framework for wider implementation of precision medicine. Wang KYX, Pupo GM, Tembe V, Patrick E, Strbenac D, Schramm SJ, Thompson JF, Scolyer RA, Muller S, Tarr G, Mann GJ, Yang JYH. NPJ Digit Med. 2022 Jul 4;5(1):85. Q1 Computer Science Applications (SJR).
  29. A multi-jurisdictional outbreak of Salmonella Typhimurium infections linked to backyard poultry-Australia, 2020. Laidlow TA, Stafford R, Jennison AV, Bell R, Graham R, Graham T, Musgrave N, Myerson M, Kung N, Crook A, Wang Q, Richards A, Lambert SB. Zoonoses Public Health. 2022 Jul 3. Q1 Veterinary (miscellaneous (SJR)).
  30. Preliminary exploration of the role of FOS immunohistochemistry in proliferative fasciitis and myositis. Vargas AC, Ma L, Talbot J, Gill AJ, Maclean FM. Histopathology. 2022 Jul 1. Q1 Histology (SJR).
  31. The tail of the giant tailgut cyst. Leung C, Kim TJ, Lendzion RJ, Henderson C, Gilmore AJ. ANZ J Surg. 2022 Jul 1. Q2 Surgery (SJR).
  32. Detection of respiratory viruses directly from clinical samples using next-generation sequencing: A literature review of recent advances and potential for routine clinical use. Wang X, Stelzer-Braid S, Scotch M, Rawlinson WD. Rev Med Virol. 2022 Jul 1: e2375. Q1 Infectious Diseases (SJR).
  33. Counting the carbon cost of heparin: an evolving tragedy of the commons? Fan BE, Favaloro EJ. Lancet Haematol. 2022 Jul;9(7): e469-e471. Q1 Hematology (SJR).
  34. Evaluation of chlorhexidine sensitization amongst healthcare workers. Anderson J, Fulton RB, Li J, Cheng I, Fernando SL. Occup Med (Lond). 2022 Jul 11;72(5):343-346. Q2 Medicine (miscellaneous (SJR)).
  35. ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo. Law AMK, Chen J, Colino-Sanguino Y, Fuente LR, Fang G, Grimes SM, Lu H, Huang RJ, Boyle ST, Venhuizen J, Castillo L, Tavakoli J, Skhinas JN, Millar EKA, Beretov J, Rossello FJ, Tipper JL, Ormandy CJ, Samuel MS, Cox TR, Martelotto L, Jin D, Valdes-Mora F, Ji HP, Gallego-Ortega D. Adv Sci (Weinh). 2022 Jul;9(21): e2103332. Q1 Biochemistry, Genetics and Molecular Biology (SJR).
  36. Comparison of six regression-based lot-to-lot verification approaches. Koh NWX, Markus C, Loh TP, Lim CY. Clin Chem Lab Med. 2022 May 16;60(8):1175-1185. Q1 Biochemistry (medical (SJR)).
  37. Serum Thrombospondin-2 Levels Are Closely Associated With the Severity of Metabolic Syndrome and Metabolic Associated Fatty Liver Disease. Wu X, Cheung CKY, Ye D, Chakrabarti S, Mahajan H, Yan S, Song E, Yang W, Lee CH, Lam KSL, Wang C, Xu A. J Clin Endocrinol Metab. 2022 Jul 14;107(8): e3230-e3240. Q1 Biochemistry (SJR).
  38. Metatranscriptomic analysis of host response and vaginal microbiome of patients with severe COVID-19. Xiao M, Lu B, Ding R, Liu X, Wu X, Li Y, Liu X, Qiu L, Zhang Z, Xie J, Chen Y, Zhang D, Dong L, Zhang M, Peng J, Yang H, Kudihna T, Xu Y, Li T, Yi C, Zhu L. Sci China Life Sci. 2022 Jul;65(7):1473-1476.
  39. Oral Epithelial Dysplasia: A Review of Diagnostic Criteria for Anatomic Pathologists. Cheung VKY, Hulme K, Schifter M, Palme C, Low TH, Clark J, Gupta R. Adv Anat Pathol. 2022 Jul 1;29(4):227-240. Q1 Anatomy (SJR).
  40. MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations. Seabrook A, Wijewardene A, De Sousa S, Wong T, Sheriff N, Gill AJ, Iyer R, Field M, Luxford C, Clifton-Bligh R, McCormack A, Tucker K. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2339-2349. Q1 Biochemistry (SJR).
  41. Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international study. Ito T, Sanford D, Tomuleasa C, Hsiao HH, Olivera LJE, Enjeti AK, Conca AG, Del Castillo TB, Girshova L, Martelli MP, Guvenc B, Bui CN, Delgado A, Duan Y, Guijarro BG, Llamas C, Lee JH. Eur J Haematol. 2022 Jul;109(1):58-68. Q1 Hematology (SJR).
  42. Getting smart with coagulation. Favaloro EJ, Pasalic L, Lippi G. J Thromb Haemost. 2022 Jul;20(7):1519-1522. Q1 Hematology (SJR).
  43. Reflectance confocal microscopy - a non-invasive tool for monitoring systemic treatment response in stage III unresectable primary scalp melanoma. Ho G, Schwartz RJ, Regio Pereira A, Dimitrou F, Paver E, McKenzie C, Saw RPM, Scolyer RA, Long GV, Guitera P. J Eur Acad Dermatol Venereol. 2022 Jul;36(7): e583-e585. Q1 Dermatology (SJR).
  44. An Analysis of the Sensitivity of the Activated Partial Thromboplastin Time (APTT) Assay, as Used in a Large Laboratory Network, to Coagulation Factor Deficiencies. Do L, Favaloro E, Pasalic L. Am J Clin Pathol. 2022 Jul 1;158(1):132-141. Q1 Medicine (miscellaneous (SJR)).
  45. Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study. Henriette Zweijpfenning SM, Chiron R, Essink S, Schildkraut J, Akkerman OW, Aliberti S, Altenburg J, Arets B, van Braeckel E, Delaere B, Gohy S, Haarman E, Lorent N, McKew G, Morgan L, Wagner D, van Ingen J, Hoefsloot W. Chest. 2022 Jul;162(1):76-81. Q1 Cardiology and Cardiovascular Medicine (SJR).
  46. Ordering Characteristics of Anti-Heat Shock Protein 70 Antibody in Australasia. Lee AYS. J Audiol Otol. 2022 Jul;26(3):166-167. Q2 Speech and Hearing (SJR).
  47. Regarding 'Human dirofilariosis in the 21st century: A scoping review of clinical cases reported in the literature'. Pupić-Bakrač A, Pupić-Bakrač J, Beck A, Jurković D, Polkinghorne A, Beck R. Transbound Emerg Dis. 2022 Jul;69(4):1666-1667. Q1 Medicine (miscellaneous (SJR)).
  48. Why Choose a Pathology Career? Fielder T, Watts F, Howden C, Gupta R, McKenzie C. Arch Pathol Lab Med. 2022 Jul 1;146(7):903-910. Q1 Medical Laboratory Technology (SJR).
  49. Men with FMR1 premutation alleles of less than 71 CGG repeats have low risk of being affected with fragile X-associated tremor/ataxia syndrome (FXTAS). Martin EM, Zhu Y, Kraan CM, Kumar KR, Godler DE, Field M. J Med Genet. 2022 Jul;59(7):706-709. Q1 Genetics (SJR).
  50. A new era of genetic testing in congenital heart disease: A review. Morrish AM, Smith J, Enriquez A, Sholler GF, Mervis J, Dunwoodie SL, Kirk EP, Winlaw DS, Blue GM. Trends Cardiovasc Med. 2022 Jul;32(5):311-319. Q1 Cardiology and Cardiovascular Medicine (SJR).

 

JUNE 2022

  1. Effect of nucleated cell count and cryopreservation on engraftment post autologous stem cell transplant. Welschinger L, Milton C, Zaunders G, Ashraf A. Transfus Apher Sci. 2022 Jun 22:103495. Q3 Hematology (SJR).
  2. Proficiency testing for SARS-CoV-2 whole genome sequencing. Lau KA, Horan K, Gonçalves da Silva A, Kaufer A, Theis T, Ballard SA, Rawlinson WD. Pathology. 2022 Jun 28: S0031-3025(22)00172-6. Q1 Pathology and Forensic Medicine (SJR).
  3. [18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial. Douglas A, Thursky K, Spelman T, Szer J, Bajel A, Harrison S, Tio SY, Bupha-Intr O, Tew M, Worth L, Teh B, Chee L, Ng A, Carney D, Khot A, Haeusler G, Yong M, Trubiano J, Chen S, Hicks R, Ritchie D, Slavin M. Lancet Haematol. 2022 Jun 28: S2352-3026(22)00166-1. Q1 Hematology (SJR).
  4. Synchronous sinonasal and respiratory papilloma: could long-term positive pressure ventilation be the cause? A rare case report. Kumar SA, O'Meara C, Paulus F, Wise L, Havas T. J Surg Case Rep. 2022 Jun 28;2022(6): rjac302. Q4 Surgery (SJR).
  5. Epidemiology, Antimicrobial Resistance, and Virulence Determinants of Group B Streptococcus in an Australian Setting. Jones S, Newton P, Payne M, Furfaro L. Front Microbiol. 2022 Jun 14; 13:839079. Q1 Microbiology (SJR).
  6. Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases. Lawless AK, Coker DJ, Lo SN, Ahmed T, Scolyer RA, Ch'ng S, Nieweg OE, Shannon K, Spillane A, Stretch JR, Thompson JF, Saw RPM. Ann Surg Oncol. 2022 Jun 30. Q1 Surgery (SJR).
  7. WHO Classification of Tumours 5th Edition: Evolving Issues in Classification, Diagnosis and Prognostication of Prostate Cancer. Kench JG, Amin MB, Berney DM, Compérat EM, Cree IA, Gill AJ, Hartmann A, Menon S, Moch H, Netto GJ, Raspollini MR, Rubin MA, Tan PH, Tsuzuki T, Turjalic S, van der Kwast TH, Zhou M, Srigley JR. Histopathology. 2022 Jun 27. Q1 Histology (SJR).
  8. Harmonizing platelet function analyzer testing and reporting in a large laboratory network. Favaloro EJ, Mohammed S, Vong R, Chapman K, Kershaw G, Just S, Connelly L, Ryan M, Zebeljan D, Brighton T, Pasalic L. Int J Lab Hematol. 2022 Jun 26. Q2 Biochemistry (chemical (SJR)).
  9. A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia. Hsu H, Chan MV, Armstrong PC, Crescente M, Donikian D, Kondo M, Brighton T, Chen V, Chen Q, Connor D, Joseph J, Morel-Kopp MC, Stevenson WS, Ward C, Warner TD, Rabbolini DJ. Pathology. 2022 Jun 21: S0031-3025(22)00168-4. Q1 Pathology and Forensic Medicine (SJR).
  10. Deep Sequencing of Early T Stage Colorectal Cancers Reveals Disruption of Homologous Recombination Repair in Microsatellite Stable Tumours with High Mutational Burdens. Li J, Steffen P, Tse BCY, Ahadi MS, Gill AJ, Engel AF, Molloy MP. Cancers (Basel). 2022 Jun 14;14(12):2933. Q1 Oncology (SJR).
  11. Meningococcal Surveillance Australia Reporting period 1 January to 31 March 2022. Lahra MM, Ray S, Hogan TR. Commun Dis Intell (2018). 2022 Jun 23;46.
  12. Molecular typing of enteroviruses: comparing 5'UTR, VP1 and whole genome sequencing methods. Gulholm T, Yeang M, Nguyen I, Andrews PI, Balgahom R, Beresford R, Branley J, Briest R, Britton P, Burrell R, Gehrig N, Kesson A, Kok J, Maley M, Newcombe J, Samarasekara H, Van Hal S, Varadhan H, Thapa K, Jones S, Newton P, Naing Z, Stelzer-Braid S, Rawlinson W. Pathology. 2022 Jun 20: S0031-3025(22)00169-6. Q1 Pathology and Forensic Medicine (SJR).
  13. Primary pancreatic spindle cell sarcoma with a TMEM106B::BRAF gene fusion treated with MEK inhibition. Mitchell C, Malalasekera V, Gill AJ, Vissers JHA, Luen SJ, Grimmond SM, Lewin J. Pathology. 2022 Jun 20: S0031-3025(22)00170-2. Q1 Pathology and Forensic Medicine (SJR).
  14. Heparin: The Journey from Parenteral Agent to Nasal Delivery. Carpenè G, Negrini D, Lippi G, Favaloro EJ, Montagnana M. Semin Thromb Hemost. 2022 Jun 22. Q1 Cardiology and Cardiovascular Medicine (SJR).
  15. Incidental findings in brain imaging research: spotlight on ethical considerations. Bhaskar SMM. Eur Radiol. 2022 Jun 22. Q1 Medicine (miscellaneous (SJR)).
  16. Unusual presentations of central nervous system myeloid sarcoma. Chatterton S, Helou J, Drummond J, Gill AJ, Ward C, Coyle L, Kerridge I, Ng K. Intern Med J. 2022 Jun;52(6):1083-1088. Q2 Internal Medicine (SJR).
  17. Circulation of enterovirus D68 (EV-D68) causing respiratory illness in New South Wales, Australia, between August 2018 and November 2019. Stelzer-Braid S, Yeang M, Britton PN, Kim KW, Varadhan H, Andrews PI, Briest R, Branley J, Balgahom R, Burrell R, Gehrig N, Newcombe J, Kesson A, Kok J, Maley M, Van Hal S, MacIntyre CR, Craig ME, Ferson MJ, Rawlinson WD. Pathology. 2022 Jun 15: S0031-3025(22)00161-1. Q1 Pathology and Forensic Medicine (SJR).
  18. Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021. Burton EM, Amaria RN, Cascone T, Chalabi M, Gross ND, Mittendorf EA, Scolyer RA, Sharma P, Ascierto PA. J Transl Med. 2022 Jun 15;20(1):271. Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  19. Interference by macroprolactin in assays for prolactin: will the In Vitro Diagnostics Regulation lead to a solution at last? Fahie-Wilson MN, Cobbaert CM, Horvath AR, Smith TP. Clin Chem Lab Med. 2022 Jun 15. Q1 Biochemistry (medical (SJR)).
  20. Morphometrics of the Tropical Bed Bug (Hemiptera: Cimicidae) From Cape Coast, Ghana. Deku G, Combey R, Doggett SL. J Med Entomol. 2022 Jun 15: tjac072. Q1 Insect Science (SJR).
  21. Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-resolution Computed Tomography. Walsh SL, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Am J Respir Crit Care Med. 2022 Jun 13. Q1 Critical Care and Intensive Care Medicine (SJR).
  22. Is the future of peer review automated? Schulz R, Barnett A, Bernard R, Brown NJL, Byrne JA, Eckmann P, Gazda MA, Kilicoglu H, Prager EM, Salholz-Hillel M, Ter Riet G, Vines T, Vorland CJ, Zhuang H, Bandrowski A, Weissgerber TL. BMC Res Notes. 2022 Jun 11;15(1):203. Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  23. Isolated cerebral toxoplasmosis 17 years post renal transplant. Cohen A, Sugo E, Chacko B. Transpl Infect Dis. 2022 Jun 11: e13880. Q2 Transplantation (SJR).
  24. Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy. Attrill GH, Owen CN, Ahmed T, Vergara IA, Colebatch AJ, Conway JW, Nahar KJ, Thompson JF, Pires da Silva I, Carlino MS, Menzies AM, Lo S, Palendira U, Scolyer RA, Long GV, Wilmott JS. J Immunother Cancer. 2022 Jun;10(6): e004771. Q1 Cancer Research (SJR).
  25. Counting the carbon cost of heparin: an evolving tragedy of the commons? Fan BE, Favaloro EJ. Lancet Haematol. 2022 Jul;9(7): e469-e471. Q1 Hematology (SJR).
  26. Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease. Dedrick RM, Smith BE, Cristinziano M, Freeman KG, Jacobs-Sera D, Belessis Y, Whitney Brown A, Cohen KA, Davidson RM, van Duin D, Gainey A, Garcia CB, Robert George CR, Haidar G, Ip W, Iredell J, Khatami A, Little JS, Malmivaara K, McMullan BJ, Michalik DE, Moscatelli A, Nick JA, Tupayachi Ortiz MG, Polenakovik HM, Robinson PD, Skurnik M, Solomon DA, Soothill J, Spencer H, Wark P, Worth A, Schooley RT, Benson CA, Hatfull GF. Clin Infect Dis. 2022 Jun 9: ciac453. Q1 Infectious Diseases (SJR).
  27. L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases. Barnhill R, van Laere S, Vermeulen P, Roman-Roman S, Gardrat S, Alsafadi S, Tarin M, Champenois G, Nicolas A, Matet A, Cassoux N, Servois V, Rodrigues M, Scolyer R, Lazar A, Romano E, Piperno-Neumann S, Mariani P, Lugassy C. Lab Invest. 2022 Jun 7. Q1 Pathology and Forensic Medicine (SJR).
  28. Whole genome duplication in oral squamous cell carcinoma in patients younger than 50 years: implications for prognosis and adverse clinicopathological factors. Satgunaseelan L, Strbenac D, Willet C, Chew T, Sadsad R, Wykes J, Low TH, Cooper WA, Lee CS, Palme CE, Yang JYH, Clark JR, Gupta R. Genes Chromosomes Cancer. 2022 Jun 7. Q1 Genetics (SJR).
  29. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial. Reijers ILM, Menzies AM, van Akkooi ACJ, Versluis JM, van den Heuvel NMJ, Saw RPM, Pennington TE, Kapiteijn E, van der Veldt AAM, Suijkerbuijk KPM, Hospers GAP, Rozeman EA, Klop WMC, van Houdt WJ, Sikorska K, van der Hage JA, Grünhagen DJ, Wouters MW, Witkamp AJ, Zuur CL, Lijnsvelt JM, Torres Acosta A, Grijpink-Ongering LG, Gonzalez M, Jóźwiak K, Bierman C, Shannon KF, Ch'ng S, Colebatch AJ, Spillane AJ, Haanen JBAG, Rawson RV, van de Wiel BA, van de Poll-Franse LV, Scolyer RA, Boekhout AH, Long GV, Blank CU. Nat Med. 2022 Jun;28(6):1178-1188. Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  30. Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis. Wong DD, van Zuylen WJ, Novos T, Stocker S, Reuter SE, Au J, Foster CSP, Day RO, Horvath AR, Endre Z, Rawlinson WD. Microbiol Spectr. 2022 Jun 29;10(3): e0268421. Q1 Cell Biology (SJR).
  31. Selpercatinib treatment of RET mutated thyroid cancers is associated with gastrointestinal adverse effects. Tsang V, Gill A, Gild M, Lurie B, Blumer L, Siddall R, Clifton-Bligh R, Robinson B. J Clin Endocrinol Metab. 2022 Jun 1: dgac337. Q1 Biochemistry (SJR).
  32. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia. Aggarwal A, Stella AO, Walker G, Akerman A, Esneau C, Milogiannakis V, Burnett DL, McAllery S, Silva MR, Lu Y, Foster CSP, Brilot F, Pillay A, Van Hal S, Mathivanan V, Fichter C, Kindinger A, Hoppe AC, Munier ML, Amatayakul-Chantler S, Roth N, Coppola G, Symonds GP, Schofield P, Jackson J, Lenthall H, Henry JY, Mazigi O, Jäck HM, Davenport MP, Darley DR, Matthews GV, Khoury DS, Cromer D, Goodnow CC, Christ D, Robosa R, Starck DJ, Bartlett NW, Rawlinson WD, Kelleher AD, Turville SG. Nat Microbiol. 2022 Jun;7(6):896-908. Q1 Applied Microbiology and Biotechnology (SJR).
  33. Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care. Ariens J, Horvath AR, Yang J, Choy KW. Endocrine. 2022 Jun;77(1):11-20. Q2 Endocrinology (SJR).
  34. A Retrospective Cohort Study with Validation of Predictors of Differentiated Thyroid Cancer Outcomes. Wijewardene A, Gill AJ, Gild M, Learoyd DL, Glover AR, Sywak M, Sidhu S, Roach P, Schembri G, Hoang J, Robinson B, Tacon L, Clifton-Bligh R. Thyroid. 2022 Jun 30. Q1 Endocrinology (SJR).
  35. Repeat Expansion Disorders: Bridging the Gap. Kirk EP. Clin Chem. 2022 Jun 1;68(6):748-750. Q1 Biochemistry (medical (SJR)).
  36. Molecular factors governing perineural invasion in malignancy. Ahmadi N, Kelly G, Low TH, Clark J, Gupta R. Surg Oncol. 2022 Jun; 42:101770. Q2 Surgery (SJR).
  37. Characterizing piggyBat-a transposase for genetic modification of T cells. Sutrave G, Xu N, Tang TCY, Dolnikov A, Gloss B, Gottlieb DJ, Micklethwaite KP, Gowrishankar K. Mol Ther Methods Clin Dev. 2022 Mar 22; 25:250-263. Q1 Genetics (SJR).
  38. Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement. Enjeti AK, Agarwal R, Blombery P, Chee L, Chua CC, Grigg A, Hamad N, Iland H, Lane S, Perkins A, Singhal D, Tate C, Tiong IS, Ross DM. Pathology. 2022 Jun;54(4):389-398. Q1 Pathology and Forensic Medicine (SJR).
  39. Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput. Phan T, Tran NYK, Gottlieb T, Siarakas S, McKew G. Pathology. 2022 Jun;54(4):466-471. Q1 Pathology and Forensic Medicine (SJR).
  40. SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability. Foster CSP, Madden M, Chan R, Agapiou D, Bull RA, Rawlinson WD, Van Hal SJ. Pathology. 2022 Jun;54(4):499-501. Q1 Pathology and Forensic Medicine (SJR).
  41. Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories. Lau KA, Kaufer A, Gray J, Theis T, Rawlinson WD. Pathology. 2022 Jun;54(4):472-478. Q1 Pathology and Forensic Medicine (SJR).
  42. Rapid FISH results within one hour. Wren C, Tegg E. Cancer Genet. 2022 Jun;264-265:66-70. Q3 Cancer Research (SJR).
  43. A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Lee CSM, Liang HPH, Connor DE, Dey A, Tohidi-Esfahani I, Campbell H, Whittaker S, Capraro D, Favaloro EJ, Donikian D, Kondo M, Hicks SM, Choi PY, Gardiner EE, Clarke LJ, Tran H, Passam FH, Brighton TA, Chen VM. Blood Adv. 2022 Jun 14;6(11):3494-3506. Q1 Hematology (SJR).
  44. Sudden cardiac deaths have higher proportion of left stellate ganglionitis. Tse R, Garland J, McCarthy S, Ondruschka B, Bardsley EN, Wong CX, Stables S, Paton JFR. Forensic Sci Med Pathol. 2022 Jun;18(2):156-164. Q2 Pathology and Forensic Science (SJR).
  45. eLearning significantly improves maternity professionals' knowledge of the congenital cytomegalovirus prevention guidelines. Smithers-Sheedy H, Swinburn K, Waight E, King R, Hui L, Jones CA, Daly K, Rawlinson W, Mcintyre S, Webb A, Badawi N, Bowen A, Britton PN, Palasanthiran P, Lainchbury A, Shand A. Aust N Z J Obstet Gynaecol. 2022 Jun;62(3):445-452. Q2 Medicine (miscellaneous (SJR)).
  46. Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metastatic melanoma: Pathogenesis, immunohistochemical analysis and treatment. Star P, Jackett LA, Cheung K, Wilmott JS, Ho G, Smith A, Long GV, Scolyer RA, Martin LK. Dermatol Ther. 2022 Jun;35(6): e15472. Q2 Dermatology (SJR).
  47. The decline of invasive meningococcal disease and influenza in the time of COVID-19: the silver linings of the pandemic playbook. George CR, Booy R, Nissen MD, Lahra MM. Med J Aust. 2022 Jun 6;216(10):504-507. Q1 Medicine (miscellaneous (SJR).
  48. Myeloid sarcoma and extramedullary hematopoiesis expand the spectrum of ERG-positive proliferations: an ancillary tool in the diagnosis. Vargas AC, Turner J, Burchett I, Ho LL, Zumbo R, Gill AJ, Maclean FM. Hum Pathol. 2022 Jun; 124:1-13. Q1 Pathology and Forensic Medicine (SJR).
  49. Machine learning models outperform manual result review for the identification of wrong blood in tube errors in complete blood count results. Farrell CL, Giannoutsos J. Int J Lab Hematol. 2022 Jun;44(3):497-503. Q2 Biochemistry (chemical (SJR)).
  50. Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Cochran AJ, Wen DR, Huang RR, Abrishami P, Smart C, Binder S, Scolyer RA, Thompson JF, Stern S, Van Kreuningen L, Elashoff DE, Sim MS, Wang HJ, Faries MB; MSLT-I Study Group. Eur J Surg Oncol. 2022 Jun;48(6):1280-1287. Q1 Medicine (miscellaneous (SJR)).
  51. A multi-laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network. Favaloro EJ, Mohammed S, Vong R, Chapman K, Swanepoel P, Kershaw G, Cai N, Just S, Connelly L, Brighton T, Pasalic L. Int J Lab Hematol. 2022 Jun;44(3):654-665. Q2 Biochemistry (chemical (SJR)).
  52. Impact of diabetes on clinical and safety outcomes in acute ischemic stroke patients receiving reperfusion therapy: A meta-analysis. Bradley SA, Smokovski I, Bhaskar SMM. Adv Clin Exp Med. 2022 Jun;31(6):583-596. Q1 Reviews and References (medical (SJR)).
  53. Successful treatment of eruptive keratoacanthomas with actitretin for patients on checkpoint inhibitor immunotherapy. Schwartz RJ, Ho G, Smith A, Collgros H, Regio Pereira A, Gouveia B, Long GV, Menzies AM, Potter AJ, Paver E, Star P, Scolyer RA, Martin LK. J Eur Acad Dermatol Venereol. 2022 Jun;36(6): e445-e448. Q1 Dermatology (SJR).
  54. Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? Semsarian CR, Ma T, Nickel B, Scolyer RA, Ferguson PM, Soyer HP, Parker L, Barratt A, Thompson JF, Bell KJL. Br J Dermatol. 2022 Jun;186(6):1030-1032. Q1 Dermatology (SJR).
  55. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients. Fuchs TL, Maclean F, Turchini J, Vargas AC, Bhattarai S, Agaimy A, Hartmann A, Kao CS, Ellis C, Bonert M, Leroy X, Kunju LP, Schwartz L, Matsika A, Williamson SR, Rao P, Divatia M, Guarch R, Algaba F, Balancin ML, Zhou M, Samaratunga H, da Cunha IW, Brimo F, Ryan A, Clouston D, Aron M, O'Donnell M, Chan E, Hirsch MS, Moch H, Pang CY, Wah C, Yin W, Perry-Keene J, Yilmaz A, Chou A, Clarkson A, van der Westhuizen G, Morrison E, Zwi J, Hes O, Trpkov K, Gill AJ. Mod Pathol. 2022 Jun;35(6):836-849. Q1 Pathology and Forensic Medicine (SJR).
  56. Medicolegal Implications of Fatalities Because of Entanglement in the Augers of Feed Mixer Wagons. Moreschi C, Da Broi U, Tse R, Garland J, Ondruschka B, Cividino SR, Vello M, Gubiani R. Am J Forensic Med Pathol. 2022 Jun 1;43(2):157-165. Q3 Medicine (miscellaneous (SJR)).
  57. A Critical Assessment of Current Grading Schemes for Diffuse Pleural Mesothelioma With a Proposal for a Novel Mesothelioma Weighted Grading Scheme (MWGS). Fuchs TL, Chou A, Aksoy Y, Mahjoub M, Sheen A, Sioson L, Ahadi M, Gill AJ. Am J Surg Pathol. 2022 Jun 1;46(6):774-785. Q1 Anatomy (SJR).
  58. Interobserver agreement of estimating the extent of intestinal metaplasia in patients with chronic atrophic gastritis. Lerch JM, Pai RK, Brown I, Gill AJ, Jain D, Kővári B, Kushima R, Sheahan K, Slavik T, Srivastava A, Lauwers GY, Langner C. Virchows Arch. 2022 Jun;480(6):1277-1281. Q1 Medicine (miscellaneous (SJR)).
  59. Multi-Trait Genetic Analysis Identifies Autoimmune Loci Associated with Cutaneous Melanoma. Liyanage UE, MacGregor S, Bishop DT, Shi J, An J, Ong JS, Han X, Scolyer RA, Martin NG, Medland SE, Byrne EM, Green AC, Saw RPM, Thompson JF, Stretch J, Spillane A, Jiang Y, Tian C; 23andMe Research Team, Gordon SG, Duffy DL, Olsen CM, Whiteman DC, Long GV, Iles MM, Landi MT, Law MH. J Invest Dermatol. 2022 Jun;142(6):1607-1616. Q1 Biochemistry (SJR).
  60. Unusual oral mucosal ulceration post allogenic hematopoietic stem cell transplantation. Schifter M, Kwan J, Kang M, Kwong K, Lee A, Sukumar S, Lin MW. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022 Jun;133(6):618-625. Q2 Dentistry (miscellaneous (SJR)).
  61. What Do Biomedical Researchers Want from Biobanks? Results of an Online Survey. Rush A, Catchpoole DR, Reaiche-Miller G, Gilbert T, Ng W, Watson PH, Byrne JA. Biopreserv Biobank. 2022 Jun;20(3):271-282. Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  62. A rare case of high grade myxoinflammatory fibroblastic sarcoma of the neck with PRAME immuno-expression: a potential pitfall. Pulvers JN, Roberts ST, Wignall A, Chan RCF, Muljono A, Toon CW. Pathology. 2022 Jun;54(4):486-488. Q1 Pathology and Forensic Medicine (SJR).
  63. How Many Health Research Biobanks Are There? O'Donoghue S, Dee S, Byrne JA, Watson PH. Biopreserv Biobank. 2022 Jun;20(3):224-228. Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  64. Digital subtraction angiography in cerebrovascular disease: current practice and perspectives on diagnosis, acute treatment and prognosis. Shaban S, Huasen B, Haridas A, Killingsworth M, Worthington J, Jabbour P, Bhaskar SMM. Acta Neurol Belg. 2022 Jun;122(3):763-780. Q2 Medicine (miscellaneous (SJR)).
  65. The utility of surrogate markers in predicting HLA alleles associated with adverse drug reactions in Vietnamese. Nguyen DV, Anderson J, Vidal C, Fulton R, Li J, Fernando SL. Asian Pac J Allergy Immunol. 2022 Jun;40(2):134-140, Q1 Medicine (miscellaneous (SJR)).

 

For earlier publications go to our archived publications here.